HONG KONG, Feb. 6, 2020
/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or
the "Company"), China's leading
provider of cord blood collection, laboratory testing,
hematopoietic stem cell processing and stem cell storage services,
today announced the appointment of Mr. Siu Chuen Cheng as a new independent
non-executive director to the Board of Directors of the Company
(the "Board").
Mr. Cheng will join the Board as a class C independent
non-executive director, effective immediately. He will also
join the Company's Special Committee as a member, and the
Compensation Committee as a member. Meanwhile, Mr. Mark D. Chen will resign from the Compensation
Committee, and Dr. Ken Lu will
replace Mr. Mark D. Chen's position
as Chairperson of the Compensation Committee. With the addition of
Mr. Cheng, the Board has been expanded to eight (8) members.
Mr. Cheng currently serves as a partner at the law firm of
C&T Legal LLP and also serves as a consultant to China Minsheng
Financial Holding Corporation Ltd. Mr. Cheng has over 10 years' of
experience in legal and compliance for corporations and banks, and
has been providing year-round legal consultancy for various banks
and solicitors. Prior to his current positions, Mr. Cheng acted as
the consultant to the legal and compliance function for various
legal firms and banks such as KCL & Partners Solicitors, Cheung
& Liu Solicitors, and China Minsheng Banking Corp., Ltd
(Hong Kong Branch). He was the
head of the legal and compliance department of China Minsheng
Banking Corp., Ltd (Hong Kong
Branch) between 2014 and 2016. He also worked for Dah Sing Bank,
China Construction Bank, Wing Lung Bank, and Baker McKenzie,
solicitors. Mr. Cheng was admitted as a solicitor in Hong Kong and obtained the International
Diploma in Compliance awarded in association with the University of
Manchester Business School in 2009. He also obtained a Bachelor of
Laws (LLB) in Chinese Law from Tsinghua University in 2005, a
Postgraduate Certificate in Laws (PCLL) from The University of Hong Kong ("HKU") in 2001, and a
Graduate Diploma in English and Hong Kong Law (CPE) from HKU and
Manchester Metropolitan University.
"We are very delighted and excited to welcome Mr. Cheng to the
team," said Ms. Ting Zheng, Chairperson and Chief Executive
Officer of GCBC. "We believe that with his extensive professional
experience and knowledge in legal and compliance and Chinese laws,
Mr. Cheng will strengthen GCBC's Board composition in China's evolving cord blood banking industry.
We look forward to his future contributions to our business."
About Global Cord Blood Corporation
Global Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with multiple licenses. Global
Cord Blood Corporation provides cord blood collection, laboratory
testing, hematopoietic stem cell processing and stem cell storage
services. For more information, please visit the Company's website
at: http://www.globalcordbloodcorp.com.
For more information, please contact:
Global Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@globalcordbloodcorp.com
ICR, Inc.
William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
Email: William.zima@icrinc.com
View original
content:http://www.prnewswire.com/news-releases/global-cord-blood-corporation-appoints-mr-siu-chuen-cheng-as-independent-non-executive-director-301000008.html
SOURCE Global Cord Blood Corporation